Agrawal, R., Sharma, S., Bekir, J., Conway, G., Bailey, J., Balen, A. H., & Prelevic, G. (2004). Prevalence of polycystic ovaries and polycystic ovary syndrome in lesbian women compared with heterosexual women. Fertility and Sterility, 82(5), 1352–1357. https://doi.org/10.1016/j.fertnstert.2004.04.041 Almeling, R. (2022). Social inequalities, reproductive bodies, and technological interventions. Journal of Marketing Management. https://doi.org/10.1080/0267257X.2021.2000234 Almeling, R. (2020). GUYnecology: The missing science of men’s reproductive health. Oakland, CA: University of California Press. Alwan, S., & Chambers, C. D. (2015). Identifying human teratogens: An update. Journal of Pediatric Genetics, 4(2), 39-41. https://doi.org/10.1055/s-0035-1556745 Angelotta, C., & Wisner, K. L. (2017). Treating depression during pregnancy: Are we asking the right questions? Birth Defects Research, 109, 879-887. https://doi-org.proxy1.cl.msu.edu/10.1002/bdr2.1074 Arterburn, D. E., Johnson, E., Coleman, K. J., Herrinton, L. J., Courcoulas, A. P., Fisher, D., Li, R. A., Theis, M. K., Liu, L., Fraser, J. R., and Haneuse, S. (2021). Weight outcomes of sleeve gastrectomy and gastric bypass compared to nonsurgical outcomes. Annals of Surgery, 274(6), e1269-e1276. https://doi.org/10.1097/sla.0000000000003826 Baba, T., Endo, T., Honnma, H., Kitajima, Y., Hayashi, T., Ikeda, H., Masumori, N., Kamiya, H., Moriwaka, O., & Saito, T. (2007). Association between polycystic ovary syndrome and female-to-male transsexuality. Human Reproduction, 22(4), 1011–1016. https://doi.org/10.1093/humrep/del474 Byne, W. (2006). Developmental endocrine influences on gender identity: Implications for management of disorders of sex development. Mount Sinai Journal of Medicine, 73(7), 950-959. https://pubmed.ncbi.nlm.nih.gov/17195880/ Cesta, C. E., Öberg, A. S., Ibrahimson, A., Yusuf, I., Larsson, H., Almqvist, C., D’Onofrio, B. M., Bulik, C. M., Fernández de la Cruz, L., Mataix-Cols, D., Landén, M., & Rosenqvist, M. A. (2020). Maternal polycystic ovary syndrome and risk of neuropsychiatric disorders in offspring: Prenatal androgen exposure or genetic confounding? Psychological Medicine, 50(4), 616–624. https://doi.org/10.1017/S0033291719000424 Chan, K. J., Liang, J. J., Jolly, D., Weinand, J. D., & Safer, J. D. (2018). Exogenous testosterone does not induce or exacerbate the metabolic features associatd with PCOS among transgender men. Endocrine Practice, 24(6), 565-572. https://pubmed.ncbi.nlm.nih.gov/29624102/ Charmaz, K. (2006). Constructing grounded theory: A practical guide through qualitative analysis. Thousand Oaks, CA: SAGE Publications. Cho, K., Harjee, R., Roberts, J., & Dunne, C. (2020). Fertility preservation in a transgender man without prolonged discontinuation of testosterone: A case report and literature review. Fertility and Sterility, 113(4), e17–e18. https://doi.org/10.1016/j.fertnstert.2020.02.045 Cochhetti, C., Ristori, J., Romani, A., Maggi, M., and Fisher, A. D. (2020). Hormonal treatment strategies tailored to non-binary transgender individuals. Journal of Clinical Medicine, 9, 1609. https://doi.org/10.3390/jcm9061609 Coleman, E., Radix, A. E., Bouman, W.P., Brown, G.R., de Vries, A. L. C., Deutsch, M. B., Ettner, R., Fraser, L., Goodman, M., Green, J., Hancock, A. B., Johnson, T. W., Karasic, D. H., Knudson, G. A., Leibowitz, S. F., Meyer-Bahlburg, H. F.L., Monstrey, S. J., Motmans, J., Nahata, L., ... Arcelus, J. (2022). Standards of care for the health of transgender and gender diverse people, Version 8. International Journal of Transgender Health, 23(S1), S1-S260. https://doi.org/10.1080/26895269.2022.2100644 Cruz, T. M. (2014). Assessing access to care for transgender and gender nonconforming people: A consideration of diversity in combating discrimination. Social Science & Medicine, 110, 65–73. https://doi.org/10.1016/j.socscimed.2014.03.032 Doan, L., & Grace, M. K. (2022). Factors affecting public opinion on the denial of healthcare to transgender persons. American Sociological Review, 87(2), 275–302. https://doi.org/10.1177/00031224221082233 Freeman, L. (2015). Confronting diminished epistemic privilege and epistemic injustice in pregnancy by challenging a “panoptics of the womb.” Journal of Medicine and Philosophy, 40(1), 44–68. https://doi.org/10.1093/jmp/jhu046 Gezer, E., Piro, B., Cantürk, Z., Çetinarslan, B., Sözen, M., Selek, A., Polat Işik, A., & Seal, L. J. (2021). The comparison of gender dysphoria, body image satisfaction and quality of life between treatment-naive transgender males with and without polycystic ovary syndrome. Transgender Health. https://doi.org/10.1089/trgh.2021.0061 Given, J. E., Loane, M., Garne, E., Addor, M., Bakker, M., Bertaut-Nativel, B., et al. (2018). Metformin exposure in first trimester of pregnancy and risk of all or specific congenital anomalies: exploratory case-control study. British Medical Journal, 361, k2477. https://doi.org/10.1136/bmj.k2477 Greenwald, P., Dubois, B., Lekovich, J., Pang, J. H., & Safer, J. (2022). Successful in vitro fertilization in a cisgender female carrier using oocytes retrieved from a transgender man maintained on testosterone. AACE Clinical Case Reports, 8(1), 19–21. https://doi.org/10.1016/j.aace.2021.06.007 Hakim, C., Padmanabhan, V., and Vyas, A. K. (2017). Gestational hyperandrogenism in developmental programming. Endocrinology, 158(2), 199-212. https://doi.org/10.1210/en.2016-1801 Hart, R. (2019). Generational health impact of PCOS on women and their children. Medical Sciences, 7(3), 1-8, https://doi.org/10.3390/medsci7030049 Hayek, S. E., Bitar, L., Hamdar, L. H., Mirza, F. G., and Daoud, G. (2016). Poly cystic ovarian syndrome: An updated overview. Frontiers in Physiology, 7, 124. https://doi.org/10.3389/fphys.2016.00124 Hines, S., Pearce, R., Pfeffer, C. A., Riggs, D. W., and White, F. R. (2021). Trans pregnancy: Fertility, reproduction, and body autonomy. International Journal of Transgender Health, 22(1-2), 1-5. https://doi.org/10.1080/26895269.2021.1884289 Honkasalo, J. (2019). In the shadow of eugenics: Transgender sterilisation legislation and the struggle for self-determination. In R. Pearce, I. Moon, K. Gupta, & D. L. Steinberg (Eds.), The emergence of trans: Culture, politics and everyday lives (pp. 17-33). New York: Routledge. Irwig, M. S. (2017). Testosterone therapy for transgender men. The Lancet: Diabetes and Endocrinology, 5(4), 301-311. https://doi.org/10.1016/s2213-8587(16)00036-x Kirkland, A. (2021). Dropdown rights: Categorizing transgender discrimination in healthcare technologies. Social Science & Medicine, 289, 114348. https://doi.org/10.1016/j.socscimed.2021.114348 Lagos, D. (2019). Hearing Gender: Voice-Based Gender Classification Processes and Transgender Health Inequality. American Sociological Review, 84(5), 801–827. https://doi.org/10.1177/0003122419872504 Legro, R.S., Schlaff, W. D., Diamond, M. P., Coutifaris, C., Casson, P. R., Brzyski, R. G., Christman, G. M., Trussell, J. C., Krawetz, S. A., Snyder, P. J., Ohl, D., Carson, S. A., Steinkampf, M. P., Carr, B. R., McGovern, P. G., Cataldo, N. A., Gosman, G. G., Nestler, J. E., Myers, E. R., Santoro, N., Eisenberg, E., Zhang, M., and Zhang, H. (2010). Total testosterone assays in women with polycystic ovary syndrome: Precision and correlation with hirsutism. The Journal of Clinical Endocrinology & Metabolism, 95(12), 5305-5313. https://doi.org/10.1210/jc.2010-1123 Light, A. D., Obedin-Maliver, J., Sevelius, J., and Kerns, J. L. (2014). Transgender men who experienced pregnancy after female-to-male gender transitioning. Obstetrics & Gynecology, 124(6), 1120-1127. https://doi.org/10.1097/aog.0000000000000540 MacKendrick, N. (2018). Better safe than sorry: How consumers navigate exposures to everyday toxins. Oakland, CA: University of California Press. McDonnell, R, and Hart, R. J. (2017). Pregnancy-related outcomes for women with Polycystic Ovary Syndrome. Women’s Health, 13(3), 89-97. https://doi.org/10.1177/1745505717731971 McNaughton, D. (2010). From the womb to the tomb: Obesity and maternal responsibility. Critical Public Health, 21(2), 179-190. https://doi.org/10.1080/09581596.2010.523680 Moravek, M. B. (2018). Gender-affirming hormone therapy for transgender men. Clinical Obstetrics and Gynecology, 61(4), 687-704. https://doi.org/10.1097/grf.0000000000000398 Moravek, M. B., Kinnear, H. M., George, J., Batchelor, J., Shikanov, A., Padmanabhan, V. and Randolph, J. F. (2020). Impact of exogenous testosterone on reproduction in transgender men. Endocrinology, 161(3). https://doi.org/10.1210/endocr/bqaa014 Nardo L.G., Rai R., Backos, M., El-Gaddal, S., and Regan, L. (2002). High serum luteinizing hormone and testosterone concentrations do not predict pregnancy outcome in women with recurrent miscarriage. Fertility and Sterility, 77, 348-52. https://doi.org/10.1016/s0015-0282(01)02995-8 Obedin-Maliver, J., and Makadon, H. J. (2016). Transgender men and pregnancy. Obstetric Medicine, 9(1), 4-8. https://doi.org/10.1177%2F1753495X15612658 Oberhelman-Eaton, S., Chang, A., Gonzalez, C., Braith, A., Singh, R. J., and Lteif, A. (2021). Initiation of gender-affirming testosterone administration in a lactating transgender man. Journal of Human Lactation. https://doi.org/10.1177%2F08903344211037646 Oudshoorn, N. (1994). Beyond the natural body: An archaeology of sex hormones. London: Routledge. Paine, E. A. (2018). Embodied disruption: “Sorting out” gender and nonconformity in the doctor’s office. Social Science & Medicine, 211, 352-358. https://doi.org/10.1016/j.socscimed.2018.06.039 Palomba, S., deWilde, M. A., Falbo, A., Koster, M. P. H., La Sala, G. B., and Fauser, B. C. J. M. (2015). Pregnancy complications in women with polycystic ovary syndrome. Human Reproduction Update, 21(5), 575-592. https://doi.org/10.1093/humupd/dmv029 Pescosolido, B. A., Tuch, S. A., and Martin, J. K. (2001). The profession of medicine and the public: Examining Americans’ changing confidence in physician authority from the beginning of the ‘health care crisis’ to the era of health care reform. Journal of Health and Social Behavior, 42(1), 1-16. https://psycnet.apa.org/doi/10.2307/3090224 Poteat, T., German, D., & Kerrigan, D. (2013). Managing uncertainty: A grounded theory of stigma in transgender health care encounters. Social Science & Medicine, 84, 22-29. Radi, B. (2020). Reproductive injustice, trans rights, and eugenics. Sexual and Reproductive Health Matters, 28(1). https://doi.org/10.1080/26410397.2020.1824318 Richardson, S. R. (2021). The maternal imprint: The contested science of maternal-fetal effects. Chicago: University of Chicago Press. Riggs, D. W., Pfeffer, C. A., Hines, S., Pearce, R., and White, F. R. (2021a). Men, trans/masculine, and non-binary people and midwifery care. In M. Anderson (ed.), Midwifery Essentials: Perinatal Mental Health (pp. 182-186). Amsterdam, NL: Elsevier. Riggs, D. W., Pfeffer, C. A., Pearce, R., Hines, S., and White, F. R. (2021b). Men, trans/masculine, and non-binary people negotiating conception: Normative resistance and inventive pragmatism. International Journal of Transgender Health, 22(1-2), 6-17. https://doi.org/10.1080/15532739.2020.1808554 Riggs, D. W., Pearce, R., Pfeffer, C. A., Hines, S., White, F., & Ruspini, E. (2020). Men, trans- masculine, and non-binary people’s experiences of pregnancy loss: An international qualitative study. BMC Pregnancy and Childbirth, 20, 482. https://doi.org/10.1186/s12884-020-03166-6 Risal, S., Pei, Y., Lu, H., Manti, M., Fornes, R., Pui, H.-P., Zhao, Z., Massart, J., Ohlsson, C., Lindgren, E., Crisosto, N., Maliqueo, M., Echiburú, B., Ladrón de Guevara, A., Sir-Petermann, T., Larsson, H., Rosenqvist, M. A., Cesta, C. E., Benrick, A., … Stener-Victorin, E. (2019). Prenatal androgen exposure and transgenerational susceptibility to polycystic ovary syndrome. Nature Medicine, 25(12), 1894–1904. https://doi.org/10.1038/s41591-019-0666-1 Rotondi, N. K., Bauer, G. R., Scanlon, K., Kaay, M., Travers, R., & Travers. A. (2013). Nonprescribed hormone use and self-performed surgeries: “Do-it-yourself” transitions in transgender communities in Ontario, Canada. American Journal of Public Health, 108, 1830-1836. https://doi-org.proxy1.cl.msu.edu/10.2105/AJPH.2013.301348 Rothman, B. K. (2014). Pregnancy, birth and risk: An introduction. Health, Risk & Society, 16(1), 1-6. https://doi.org/10.1080/13698575.2013.876191 Saguy, A. (2013). What’s wrong with fat? The war on obesity and its collateral damage. New York: Oxford University Press. shuster, stef m. (2019). Performing informed consent in transgender medicine. Social Science & Medicine, 226, 190–197. https://doi.org/10.1016/j.socscimed.2019.02.053 shuster, stef m. (2021). Trans medicine: The emergence and practice of treating gender. New York: New York University Press. Siebers, T. (2008). Disability theory. Ann Arbor: University of Michigan Press. Stark, B. A., & Mok-Lin, E. (2022). Fertility preservation in transgender men without discontinuation of testosterone. Fertility and Sterility. https://doi.org/10.1016/j.xfre.2022.02.002 Susser, M. (1985). Rules of inference in epidemiology. Regulatory Toxicology and Pharmacology, 6, 116-128. Swift-Gallant, A., Johnson, B. A., Di Rita, V., & Breedlove, S. M. (2020). Through a glass, darkly: Human digit ratios reflect prenatal androgens, imperfectly. Hormones and Behavior, 120, 104686. https://doi.org/10.1016/j.yhbeh.2020.104686 Timmermans, S., & Almeling, R. (2009). Objectification, standardization, and commodification in health care: A conceptual readjustment. Social Science & Medicine, 69(1), 21–27. https://doi.org/10.1016/j.socscimed.2009.04.020 Toze, M. (2018). The risky womb and the unthinkability of the pregnant man: Addressing trans masculine hysterectomy. Feminism & Psychology, 28(2), 194-211. https://doi.org/10.1177%2F0959353517747007 T’Sjoen, G., Van Caenegem, E., & Wierckx, K. (2013). Transgenderism and reproduction. Current Opinion in Endocrinology, Diabetes & Obesity, 20(6), 575–579. https://doi.org/10.1097/01.med.0000436184.42554.b7 Valdez, N. (2021). Weighing the future: Race, science, and pregnancy trials in the postgenomic era. Oakland: University of California Press. van Dijken, J. B., Steensma, T. D., Wensing-Kruger, S. A., den Heijer, M., & Dreijerink, K. M. A. (2022). Tailored gender-affirming hormone treatment in nonbinary transgender individuals: A retrospective study in a referral center cohort. Transgender Health. Online first: https://doi.org/10.1089/trgh.2021.0032 Vincent, B. (2019). Breaking down barriers and binaries in trans healthcare: The validation of non-binary people. International Journal of Transgender Health, 20(2-3), 132-137. https://doi.org/10.1080/15532739.2018.1534075 Waggoner, M. (2017). The zero trimester: Pre-pregnancy care and the politics of reproductive risk. Oakland, CA: University of California Press. White Hughto, J. M., Reisner, S. L., & Pachankis, J. E. (2015). Transgender stigma and health: A critical review of stigma determinants, mechanisms, and interventions. Social Science & Medicine, 147, 222–231. https://doi.org/10.1016/j.socscimed.2015.11.010 Willging, C., Gunderson, L., Shattuck, D., Sturm, R., Lawyer, A., & Crandall, C. (2019). Structural competency in emergency medicine services for transgender and gender non-conforming patients. Social Science & Medicine, 222, 67–75. https://doi.org/10.1016/j.socscimed.2018.12.031 Xita, N., & Tsatsoulis, A. (2014). Review: Fetal programming of polycystic ovary syndrome by androgen excess—E¬¬vidence from experimental, clinical and genetic associa¬¬tion studies. Journal of South Asian Federation of Obstetrics and Gynaecology, 6(2), 129-130. https://doi.org/10.5005/jsafog-6-2-129